Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.

Franklin JM, Carrasco GA.

Synapse. 2013 Mar;67(3):145-59. doi: 10.1002/syn.21626. Epub 2012 Dec 8.

2.

Behavioural genetics of Alzheimer's disease: a comprehensive review.

Flirski M, Sobow T, Kloszewska I.

Arch Med Sci. 2011 Apr;7(2):195-210. doi: 10.5114/aoms.2011.22068. Epub 2011 May 17.

3.

Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.

Panza F, Seripa D, D'Onofrio G, Frisardi V, Solfrizzi V, Mecocci P, Pilotto A.

Int J Alzheimers Dis. 2011 Apr 7;2011:721457. doi: 10.4061/2011/721457.

4.

Genetics of psychosis in Alzheimer's disease: a review.

DeMichele-Sweet MA, Sweet RA.

J Alzheimers Dis. 2010;19(3):761-80. doi: 10.3233/JAD-2010-1274. Review. Erratum in: J Alzheimers Dis. 2010;20(4):1263.

5.

Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.

Wilkosz PA, Kodavali C, Weamer EA, Miyahara S, Lopez OL, Nimgaonkar VL, DeKosky ST, Sweet RA.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1054-62.

Supplemental Content

Write to the Help Desk